Subependymal giant cell astrocytoma historical perspective: Difference between revisions
| Line 11: | Line 11: | ||
*The association between subependymal nodule transformating into a subependymal giant cell astrocytoma was first described by Nabbout. | *The association between subependymal nodule transformating into a subependymal giant cell astrocytoma was first described by Nabbout. | ||
== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 15:08, 9 November 2015
|
Subependymal giant cell astrocytoma Microchapters |
|
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Subependymal giant cell astrocytoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma historical perspective |
|
FDA on Subependymal giant cell astrocytoma historical perspective |
|
CDC on Subependymal giant cell astrocytoma historical perspective |
|
Subependymal giant cell astrocytoma historical perspective in the news |
|
Blogs on Subependymal giant cell astrocytoma historical perspective |
|
Risk calculators and risk factors for Subependymal giant cell astrocytoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".[1]
Historical Perspective
- Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".[1]
- Anna et al. was the first to identify that subependymal giant cell astrocytoma demonstrated immunoreactivity for neurofilament, GFAP, substance P, and neuron-specific enolase.
- The association between subependymal nodule transformating into a subependymal giant cell astrocytoma was first described by Nabbout.